Drug delivery via the mucous membranes of the oral cavity.
about
A clinical perspective on mucoadhesive buccal drug delivery systemsDifferential Modulation of Rhythmic Brain Activity in Healthy Adults by a T-Type Calcium Channel Blocker: An MEG Study.Bioavailability of sublingual buprenorphine.Human cytomegalovirus tropism for mucosal myeloid dendritic cells.Prodrug based optimal drug delivery via membrane transporter/receptor.Characterization of thin poly(dimethylsiloxane)-based tissue-simulating phantoms with tunable reduced scattering and absorption coefficients at visible and near-infrared wavelengths.Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis.Oral bioadhesive drug delivery systems.A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methodsS-glutathionylation of buccal cell proteins as biomarkers of exposure to hydrogen peroxideBuccal drug delivery.Noninvasive delivery technologies: respiratory delivery of vaccines.Isolation and characterization of jackfruit mucilage and its comparative evaluation as a mucoadhesive and controlled release component in buccal tabletsSingle-dose fentanyl sublingual spray for breakthrough cancer painMucoadhesive bilayer tablets of propranolol hydrochloride.Preparation and evaluation of buccoadhesive films of atenololCritical evaluation of permeation enhancers for oral mucosal drug delivery.Rapidly disintegrating oramucosal drug delivery technologies.Models for oral uptake of nanoparticles in consumer products.Bioavailability of phytochemicals and its enhancement by drug delivery systems.Environmental and occupational exposure to chemicals and telomere length in human studies.Environmental and occupational exposure to chemicals and telomere length in human studies.Mucoadhesive polymers for buccal drug delivery.Enhancing the buccal mucosal delivery of peptide and protein therapeutics.Overview and appraisal of the current concept and technologies for improvement of sublingual drug delivery.Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl.Alternate Routes of Administration of Antidepressant and Antipsychotic Medications.Bioabsorbable polymers for implantable therapeutic systems.Mucoadhesive therapeutic compositions: a patent review (2011-2014).Recent advances and perspectives in topical oral anesthesia.New Non-Intravenous Routes for Benzodiazepines in Epilepsy: A Clinician Perspective.Oromucosal multilayer films for tailor-made, controlled drug delivery.Sumatriptan succinate sublingual fast dissolving thin films: formulation and in vitro/in vivo evaluation.In-vitro permeability of neutral polystyrene particles via buccal mucosa.Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa.C. dubliniensis in an immunocompetent patient with metal lingual frenulum piercing.Development and in vitro evaluation of buccoadhesive tablets of metoprolol tartrateBiointerfacial phenomena of amlodipine buccomucosal tablets of HPMC matrix system containing polyacrylate polymer/β-cyclodextrin: Correlation of swelling and drug delivery performance.Development of polymer-bound fast-dissolving metformin buccal film with disintegrants.Preparation and in vitro/in vivo characterization of porous sublingual tablets containing ternary kneaded solid system of vinpocetine with î-cyclodextrin and hydroxy Acid.
P2860
Q27023412-8267A40D-9378-4C82-97FD-1A82AF8937ADQ30837283-C80E95AA-3478-409D-B18F-B8C417C7ECFDQ34417674-6C6BE07C-0DE1-4417-8946-8307C06CE23DQ34422068-168A5C7F-86FB-4400-81A2-1D4145E97AAEQ34452034-B9C70802-7190-4824-B8EC-93872CA159FCQ34488459-F2308D37-287D-482B-9C25-016E162FE507Q35627879-8919EA71-B308-41D1-9644-6661BE6A5E89Q36097996-28E33F91-94D0-4F04-BEEF-EA3F5C82410EQ36215627-78F024B9-1B88-4274-AAC3-2F750EE06EB8Q36250882-CE62ACBC-0B1F-40A1-B7F5-A1F0B5E51358Q36316789-284E1F3E-A598-4BD6-8857-14D0F12C5271Q36349694-DCDF4E4A-0828-43DC-B52B-5F7BD1284CEEQ36352228-F6287082-B3BE-439F-AA3C-C0ED4C545975Q37053311-AA07FF58-2548-4A81-8C2A-8ED905C1C5DEQ37360864-AE05939E-5851-427D-80F0-286B0161B557Q37472668-52DF0302-DC8D-49EF-9AD7-3DBE2744AF2FQ37575468-4F359034-5A2D-4DBF-B59E-F280CEBBFDE0Q37626036-1057A679-A46D-4291-91D5-F6B89D0CF9CBQ37961539-583B6743-2F63-462F-BD1C-BE7BE79558DFQ38084084-CC7DE25D-89FA-40BA-8084-C8695B1142F0Q38115262-CFDDFEBE-EF1A-4E66-9E27-8D3A6A67F5B6Q38163523-91DDC5B3-A9AF-4F1A-B354-DF7760CF4226Q38191711-3513EF67-68C6-4615-BDBB-4BDAE40AE69BQ38244323-A08C9ADB-79DC-4A15-AD52-A2223036CEBCQ38257176-FD5C691B-4928-4792-B8DB-E06D23253436Q38394314-1782C84B-7D3E-4DC2-B255-3FF84DDAD4A4Q38439513-D576225F-3AA3-4A02-9AD4-03EB6D9B8797Q38548133-D4587D58-73C0-4D0E-AFCC-59DD1ECEC78BQ38706683-0BEA01DC-DE98-45A0-A5D0-53D062EF95BCQ38828473-BD0434C6-EFC2-4CC2-B1AB-7ADE892D4A01Q39036186-A93B783C-2010-4B0B-864C-7E8857502F38Q39044358-8C9E16B5-15B4-4FC7-A0B3-DBE094818E2BQ39195553-35034EDA-C008-461F-B065-1A02DFF72C26Q39251221-482B3279-0D89-4B34-BA4A-B419AC407FC1Q39540435-DF56389B-2904-4967-A5A6-2F6780282A27Q39637952-EA61A872-C1EF-488B-9369-C60A94E067E7Q39962688-C68706A3-CCBA-4933-A728-574717F1A06BQ39995983-C8FCAABC-9F97-48B5-8EE0-93F2A2B4801BQ41047377-1FA15E02-461E-4BCC-B8FA-1661882B2BACQ41182511-EBCFCACE-5D18-4C81-A2AB-FFA6CFF440FF
P2860
Drug delivery via the mucous membranes of the oral cavity.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Drug delivery via the mucous membranes of the oral cavity.
@ast
Drug delivery via the mucous membranes of the oral cavity.
@en
type
label
Drug delivery via the mucous membranes of the oral cavity.
@ast
Drug delivery via the mucous membranes of the oral cavity.
@en
prefLabel
Drug delivery via the mucous membranes of the oral cavity.
@ast
Drug delivery via the mucous membranes of the oral cavity.
@en
P356
P1476
Drug delivery via the mucous membranes of the oral cavity.
@en
P2093
P356
10.1002/JPS.2600810102
P407
P577
1992-01-01T00:00:00Z